PortfoliosLab logoPortfoliosLab logo
HWKN vs. AMPH
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HWKN vs. AMPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hawkins, Inc. (HWKN) and Amphastar Pharmaceuticals, Inc. (AMPH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HWKN achieves a 14.33% return, which is significantly higher than AMPH's -31.55% return. Over the past 10 years, HWKN has outperformed AMPH with an annualized return of 24.43%, while AMPH has yielded a comparatively lower 1.62% annualized return.


HWKN

1D
0.35%
1M
5.92%
YTD
14.33%
6M
9.95%
1Y
18.62%
3Y*
52.57%
5Y*
39.59%
10Y*
24.43%

AMPH

1D
-2.55%
1M
-0.43%
YTD
-31.55%
6M
-32.91%
1Y
-25.37%
3Y*
-31.55%
5Y*
-2.03%
10Y*
1.62%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HWKN vs. AMPH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
HWKN
Hawkins, Inc.
14.33%16.45%75.46%84.66%-0.81%53.05%16.44%14.35%19.23%-33.43%
AMPH
Amphastar Pharmaceuticals, Inc.
-31.55%-27.88%-39.97%120.74%20.31%15.81%4.25%-3.07%3.43%4.45%

Correlation

The correlation between HWKN and AMPH is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Jun 25, 2014

0.26

The correlation between HWKN and AMPH shifts across timeframes, from 0.15 (1 year) to 0.27 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

HWKN:

$3.38B

AMPH:

$851.58M

EPS

HWKN:

$3.91

AMPH:

$1.67

PE Ratio

HWKN:

41.41

AMPH:

10.96

PEG Ratio

HWKN:

3.21

AMPH:

0.58

PS Ratio

HWKN:

3.12

AMPH:

1.20

PB Ratio

HWKN:

6.33

AMPH:

1.10

Total Revenue (TTM)

HWKN:

$1.08B

AMPH:

$720.53M

Gross Profit (TTM)

HWKN:

$245.06M

AMPH:

$341.13M

EBITDA (TTM)

HWKN:

$162.38M

AMPH:

$155.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HWKN vs. AMPH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HWKN
HWKN Risk / Return Rank: 5555
Overall Rank
HWKN Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
HWKN Sortino Ratio Rank: 5353
Sortino Ratio Rank
HWKN Omega Ratio Rank: 5252
Omega Ratio Rank
HWKN Calmar Ratio Rank: 5454
Calmar Ratio Rank
HWKN Martin Ratio Rank: 5555
Martin Ratio Rank

AMPH
AMPH Risk / Return Rank: 2121
Overall Rank
AMPH Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
AMPH Sortino Ratio Rank: 2323
Sortino Ratio Rank
AMPH Omega Ratio Rank: 2222
Omega Ratio Rank
AMPH Calmar Ratio Rank: 2222
Calmar Ratio Rank
AMPH Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HWKN vs. AMPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Hawkins, Inc. (HWKN) and Amphastar Pharmaceuticals, Inc. (AMPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HWKNAMPHDifference
Sharpe ratioReturn per unit of total volatility

+0.98

Sortino ratioReturn per unit of downside risk

+1.24

Omega ratioGain probability vs. loss probability

1.12

0.95

+0.17

Calmar ratioReturn relative to maximum drawdown

0.54

-0.56

+1.10

Martin ratioReturn relative to average drawdown

1.10

-1.12

+2.22

HWKN vs. AMPH - Sharpe Ratio Comparison

The current HWKN Sharpe Ratio is 0.51, which is higher than the AMPH Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of HWKN and AMPH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HWKN vs. AMPH - Drawdown Comparison

The maximum HWKN drawdown since its inception was -44.76%, smaller than the maximum AMPH drawdown of -74.05%. Use the drawdown chart below to compare losses from any high point for HWKN and AMPH.


Loading charts...

Drawdown Indicators


HWKNAMPHDifference

Max Drawdown

Largest peak-to-trough decline

-44.76%

-74.05%

+29.29%

Max Drawdown (1Y)

Largest decline over 1 year

-34.79%

-45.25%

+10.46%

Max Drawdown (3Y)

Largest decline over 3 years

-34.79%

-74.05%

+39.26%

Max Drawdown (5Y)

Largest decline over 5 years

-34.79%

-74.05%

+39.26%

Max Drawdown (10Y)

Largest decline over 10 years

-44.76%

-74.05%

+29.29%

Current Drawdown

Current decline from peak

-11.86%

-71.80%

+59.94%

Average Drawdown

Average peak-to-trough decline

-15.71%

-24.16%

+8.45%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.95%

22.70%

-5.75%

Volatility

HWKN vs. AMPH - Volatility Comparison

The current volatility for Hawkins, Inc. (HWKN) is 6.84%, while Amphastar Pharmaceuticals, Inc. (AMPH) has a volatility of 11.12%. This indicates that HWKN experiences smaller price fluctuations and is considered to be less risky than AMPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HWKNAMPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.84%

11.12%

-4.28%

Volatility (6M)

Calculated over the trailing 6-month period

26.50%

46.07%

-19.57%

Volatility (1Y)

Calculated over the trailing 1-year period

36.66%

53.96%

-17.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.40%

45.16%

-8.76%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.50%

42.72%

-5.22%

Dividends

HWKN vs. AMPH - Dividend Comparison

HWKN's dividend yield for the trailing twelve months is around 0.47%, while AMPH has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AMPH
Amphastar Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
HWKN
Hawkins, Inc.
0.47%0.52%0.55%0.88%1.45%1.28%1.78%2.01%2.17%2.44%1.52%2.18%

Financials

HWKN vs. AMPH - Financials Comparison

This section allows you to compare key financial metrics between Hawkins, Inc. and Amphastar Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M150.00M200.00M250.00M300.00M20222023202420252026
265.91M
171.17M
(HWKN) Total Revenue
(AMPH) Total Revenue
Values in USD except per share items

HWKN vs. AMPH - Profitability Comparison

The chart below illustrates the profitability comparison between Hawkins, Inc. and Amphastar Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%20222023202420252026
20.4%
41.1%
Portfolio components
HWKN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Hawkins, Inc. reported a gross profit of 54.24M and revenue of 265.91M. Therefore, the gross margin over that period was 20.4%.

AMPH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported a gross profit of 70.32M and revenue of 171.17M. Therefore, the gross margin over that period was 41.1%.

HWKN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Hawkins, Inc. reported an operating income of 23.46M and revenue of 265.91M, resulting in an operating margin of 8.8%.

AMPH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported an operating income of 13.63M and revenue of 171.17M, resulting in an operating margin of 8.0%.

HWKN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Hawkins, Inc. reported a net income of 15.46M and revenue of 265.91M, resulting in a net margin of 5.8%.

AMPH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported a net income of 6.42M and revenue of 171.17M, resulting in a net margin of 3.8%.


Frequently Asked Questions


HWKN and AMPH have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMPH has higher volatility (11.12%) compared to HWKN (6.84%). In terms of maximum drawdown, HWKN dropped -44.76% vs AMPH's -74.05%.

HWKN currently has the higher Sharpe Ratio (0.51 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HWKN and AMPH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer